Nanosuspension Formulation To Maximize Potency For Preclinical Studies

A client engaged Altasciences to leverage their proactive drug development approach to expedite the preclinical development of their new active pharmaceutical ingredient (API). Their objective was to create a robust formulation with maximum potency, requiring the development of a stable and effective drug prototype from scratch. Our team proposed a comprehensive study to conceptualize, optimize, and produce a formulation that would meet the rigorous requirements for clinical trials.
This approach not only ensured the rapid progression of the API through the preclinical phase but also laid a strong foundation for its success in subsequent clinical studies, aligning with the client's goal of achieving a high-quality, stable formulation.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.